Celldex Therapeutics CLDX
NASDAQ CLDX
$28.97 -0.40 (-1.36%)
At close: Oct 22, 2026 · 4:00 PM EDT

Celldex Therapeutics (CLDX) Amortization of Deferred Charges (2010 - 2016)

Updated

Analysis

Celldex Therapeutics (CLDX) Amortization of Deferred Charges (2010 - 2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Celldex Therapeutics 2.23 Bn -39.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 1.64 Mn
Dec 31, 2015 72,000.00
Sep 30, 2015 72,000.00
Jun 30, 2015 72,000.00
Mar 31, 2015 72,000.00
Jun 30, 2013 41,000.00
Mar 31, 2013 56,000.00
Dec 31, 2012 57,000.00
Sep 30, 2012 58,000.00
Jun 30, 2012 54,000.00
Mar 31, 2012 57,000.00
Dec 31, 2011 57,000.00
Sep 30, 2011 58,000.00
Jun 30, 2011 57,000.00
Mar 31, 2011 135,000.00
Dec 31, 2010 182,000.00
Sep 30, 2010 182,000.00
API Access

Celldex Therapeutics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=CLDX&period=max&api_key=YOUR_API_KEY